Cat.#: ACPP-1544
| Despition | GAPDH Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1367 | Myocilin Blocking Peptide (AC1367) | 250 µg | inquiry |
| ACPP-1741 | Human NDRG1 Protein (AC1741) | 10 µg | inquiry |
| ACPP-1679 | Human SYT4 Protein (AC1679) | 2 µg | inquiry |
| ACPP-1675 | Human TOR1A Protein (AC1675) | 5 µg | inquiry |
| ACPP-1267 | Acrp30 Mouse, Trimeric (AC1267) | 2 µg | inquiry |
| ACPP-1833 | Human CRMP1 Protein (AC1833) | 5 µg | inquiry |
| ACPP-1547 | Human CA14 Protein (AC1547) | 5 µg | inquiry |
| ACPP-1291 | FGFR1 Blocking Peptide (AC1291) | 250 µg | inquiry |
| ACPP-1626 | Human SHC1 Protein (AC1626) | 5 µg | inquiry |
| ACPP-1306 | FGFR2 Blocking Peptide (AC1306) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.